10/07/2020
The PCR systems represent the next generation of Bio-Rad’s CFX Real-time PCR products that are used in research and genomic testing as well pathogen detection and infectious disease testing.
07/27/2020
More than 45 abstracts were presented showing the value of Droplet Digital PCR (ddPCR) technology as a tool for quantifying cancer biomarkers
06/17/2020
Bio-Rad continues to support the worldwide effort to fight SARS-CoV-2, the virus associated with COVID-19 disease, offering instruments, tests, and a SARS-CoV-2 standard to help labs validate COVID-19 assay results.
05/17/2020
Bio-Rad Laboratories Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.
05/06/2020
Out of the Blue CRISPR and Genotyping Extension kits awarded “Best New Technology Innovation for Science” and the Science of Opioid Dependence Kit won in the category of “Best Tried & True Technology Teaching and
05/06/2020
The latest imaging system from Bio-Rad’s GelDoc product line, offers sensitivity, performance, and reliability in a compact system.
02/03/2020
Bio-Rad’s ZE5 Cell Analyzer now comes with FCS Express flow cytometry analysis software from De Novo Software.
01/20/2020
During a Bio-Rad workshop, speakers will discuss how following next-generation sequencing with Droplet Digital PCR for routine serial monitoring is effective in detecting residual disease or molecular relapse.
01/09/2020
The novel technology provides a holistic view of the complete transcriptome and overcomes limitations of other available kits.
12/06/2019
Scientists will present more than 40 abstracts that used Bio-Rad’s droplet-based technologies to advance research into both malignant and non-malignant blood disorders.